title: Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial.
abstract: Insufficient clinical trial data were available to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual analogue scale (VAS, 0 to 10 cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P<.05), whereas there were no significant differences between the 2 groups in VAS scores and SF-36 physical and mental component summary scores (P>.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.
authors: Acupuncture and Moxibustion Department, Beijing Traditional Chinese Medicine Hospital affiliated with Capital Medical University, Beijing, China Acupuncture and Moxibustion Department, Beijing Tiantan Hospital affiliated with Capital Medical University, Beijing, China Acupuncture and Moxibustion Department, the Third Hospital of Peking University, Beijing, China Quintiles Medical Development (Shanghai) Co., Ltd. Beijing Branch, Beijing, China Acupuncture and Moxibustion Department, Huguosi Hospital affiliated with the Beijing University of Chinese Medicine, Beijing, China Acupuncture and Moxibustion Department, Dongzhimen Hospital affiliated with the Beijing University of Chinese Medicine, Beijing, China.
authors: Lin-Peng
authors: LP
authors: Wang
authors: Xiao-Zhe
authors: XZ
authors: Zhang
authors: Jia
authors: J
authors: Guo
authors: Hui-Lin
authors: HL
authors: Liu
authors: Yan
authors: Y
authors: Zhang
authors: Cun-Zhi
authors: CZ
authors: Liu
authors: Jing-Hong
authors: JH
authors: Yi
authors: Li-Ping
authors: LP
authors: Wang
authors: Ji-Ping
authors: JP
authors: Zhao
authors: Shan-Shan
authors: SS
authors: Li
references: Alders EE, Hentzen A, Yan CT. A community-based prevalence study on headache in Malaysia. Headache. 1996;36:379-384.
references: Alecrim-Andrade J, Maciel-Júnior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia. 2006;26:520-529.
references: Allais G, De Lorenzo C, Quirico PE, Airola G, Tolardo G, Mana O, Benedetto C. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache. 2002;42:855-861.
references: Bausell B, O’Connell NE. Acupuncture research: placebos by many other names. Arch Intern Med. 2009;169:1812-1813.
references: Bussone G, Cerbo R, Martucci N, Micieli G, Zanferrari C, Grazzi L, Fabbrini G, Cavallini A, Granella F, Ambrosoli L, Mailland F, Poli A, Manzoni G. Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study vs flunarizine. Headache. 1999;39:426-431.
references: Cheung RT. Prevalence of migraine, tension-type headache, and other headaches in Hong Kong. Headache. 2000;40:473-479.
references: Day SJ, Altman DG. Statistics notes: blinding in clinical trials and other studies. BMJ. 2000;321:504.
references: Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 2006;5:310-316.
references: Evers S, Afra J, Frese A, Goadsby PJ, Lind M, May A. Sandor PS; European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol. 2009;16:968-981.
references: Facco E, Liguori A, Petti F, Zanette G, Coluzzi F, De Nardin M, Mattia C. Traditional acupuncture in migraine: a controlled, randomized study. Headache. 2008;48:398-407.
references: Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol. 2010;9:285-298.
references: Goadsby PJ. Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol. 2006;2:401.
references: Harris RE, Zubieta JK, Scott DJ, Napadow V, Gracely RH, Clauw DJ. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage. 2009;47:1077-1085.
references: Headache Classification Subcommittee of the International Headache Society (IHS). The international classification of headache disorder, 2nd ed. Cephalalgia 2004;24:9–160.
references: Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, Rosen B, Gollub RL. An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment. Neuroimage. 2009;47:1066-1076.
references: Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;21:CD001218.
references: Linde K, Streng A, Jürgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melechart D. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005;293:2118-2125.
references: Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128:264-271.
references: Melchart D, Linde K, Fischer P, White A, Allais G, Vickers A, Berman B. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia. 1999;19:779-786.
references: Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia. 1997;17:15-22.
references: Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004;63:2022-2027.
references: Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci. 2006;27:410-415.
references: Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ. International Headache Society. The International Classification of Headache Disorders, 2nd edition (ICHD-II)—revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005;25:460-465.
references: Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11:289-299.
references: Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes MG, Wagenpfeil S, Weidenhammer W, Melechart D. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache. 2006;46:1492-1502.
references: Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765-786.
references: von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M, Oz C, Balmaceda C. Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia. 2002;22:395-400.
references: Wang LP, Liu HL, Ji J, Liu H. Observation on therapeutic effect of acupuncture on no-premonitory migraine at remission stage. Zhongguo Zhen Jiu. 2005;25:679-681.
references: Wang SJ, Fuh JL, Young YH, Lu SR, Shia BC. Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia. 2000;20:566-572.
references: Wang Y, Zheng Z, Xue C. Acupuncture for migraine: a systematic review of Chinese literature. Aust J Acupunct Chin Med. 2008;3:3-16.
references: White AR, Filshie J, Cummings TM. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med. 2001;9:237-245.
references: Witt C, Brinkhaus B, Jena S, Linde K, Streng A, Wagenpfeil S, Hummelsberger J, Walther HU, Melchart D, Willich SN. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet. 2005;366:136-143.
references: Yu J, Fang YN, Lin JW, Huang RX. Flunarizine for prophylaxis treatment in migrainous women: a controlled clinical trial. Chin J Nerv Ment Dis. 2001;27:290-291.
references: Zhang Y, Liu HL, Wang LP. Evaluation of the quality of reports on acupuncture for migraine prophylaxis. Chin J Evidence Based Med. 2008;8:461-465.
references: Zhang Y, Wang LP, Liu HL, Li N, Li JD, Yi JH. The design and protocol of acupuncture for migraine prophylaxis: a multicenter randomized controlled trial. Trials. 2009;10:25.